9. Oral dexamethasone compared to nebulised dexamethasone for croup.
Oral dexamethasone compared to nebulised dexamethasone for croup | |||||
Patient or population: children with croup Intervention: oral dexamethasone Comparison: nebulised dexamethasone | |||||
Outcomes | Anticipated absolute effects* (95% CI) | Relative effect (95% CI) | № of participants (studies) | Certainty of the evidence (GRADE) | |
Nebulised dexamethasone | Oral dexamethasone | ||||
Return visits or (re)admissions or both | Study population | RR 0.39 (0.17 to 0.89) | 176 (1 RCT) | ⊕⊕⊝⊝ LOWa, b | |
209 per 1000 | 81 per 1000 (35 to 186) | ||||
Adverse events | None of the studies reported collecting adverse events data. | ||||
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). CI: confidence interval; RCT: randomised controlled trial; RR: risk ratio | |||||
GRADE Working Group grades of evidence High certainty: We are very confident that the true effect lies close to that of the estimate of the effect. Moderate certainty: We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. Low certainty: Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect. Very low certainty: We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. |
aWe downgraded by one level for inconsistency. As there was only one study in the analysis, there was no evidence of consistency. bWe downgraded by one level for imprecision. The sample size was small (did not meet the optimal information size).